Utkalgenomics Private Limited
About Utkalgenomics Private Limited
Data last updated:
Utkalgenomics Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 13 June 2023.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U86100WB2023PTC262804.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1.03 Lakh. It is led by directors Priyanka Ray and Gyana Guru.
Its last annual general meeting (AGM) was held on 25 October 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Kolkata, West Bengal.
As per the financials filed for FY 2025, the company reported a revenue of ₹53.26 Lakh. For the same year it recorded a net profit of ₹38,921 (net margin 0.7%) and EBITDA of ₹55,934 (EBITDA margin 1.1%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressCl – 57 Ground Floor, Sector – 11, Kolkata, West Bengal, India – 700091
- IndustryHealthcare, Hospitals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Utkalgenomics Private Limited
The main business activity of Utkalgenomics is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Utkalgenomics Private Limited FY 2024 filings available
Utkalgenomics Private Limited reported revenue of ₹53.26 Lakh for FY 2025.
Financial Statement Summary of Utkalgenomics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹55,934 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹38,921 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Utkalgenomics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 1.1% | •••• |
| Net Profit Margin | 0.7% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Utkalgenomics are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Utkalgenomics Private Limited
Utkalgenomics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyanka Ray Also directs: Ezyurban LLP, Blueharvest Private Limited | Director | 18 Nov 2024 | 1 Years 11 Months | Current |
| Gyana Guru | Director | 16 Sep 2024 | 2 Years 1 Months | Current |
Peer Comparison of Utkalgenomics Private Limited
Utkalgenomics Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Human health activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Drkulkarni Specialty Diagnostic Lab India Private Limited | ₹53.59 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | Virar, Maharashtra, India |
| Sankalp Gynaecare Private Limited | ₹53.57 Lakh (FY 2025) | •••• | •••• | 83.0% | •••• | Jaipur, Rajasthan, India |
| Eye-Care Vinayak Siddhi Hospital Private Limited | ₹53.41 Lakh (FY 2025) | •••• | •••• | 82.0% | •••• | Lucknow, Uttar Pradesh, India |
| NGN Health Care India Private Limited | ₹53.35 Lakh (FY 2025) | •••• | •••• | 154.0% | •••• | Nellore, Andhra Pradesh, India |
| Humanlife Pharmaceuticals Private Limited | ₹53.28 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | Mumbai, Maharashtra, India |
| Utkalgenomics Private Limited this company | ₹53.26 Lakh (FY 2025) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Bhagchand Healthcare Private Limited | ₹53.2 Lakh (FY 2025) | •••• | •••• | 94.0% | •••• | Morena, Madhya Pradesh, India |
| Touch Pathological & Imaging Centre Private Limited | ₹53.11 Lakh (FY 2024) | •••• | •••• | 14.0% | •••• | Jalpaiguri, West Bengal, India |
| Mother Nursing Home Private Limited | ₹53.02 Lakh (FY 2025) | •••• | •••• | -5.0% | •••• | Kolkata, West Bengal, India |
| Devgiri Diagnostics Private Limited | ₹52.87 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Pune, Maharashtra, India |
| Vedshri Biomedical Private Limited | ₹52.76 Lakh (FY 2024) | •••• | •••• | •••• | Noida, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Utkalgenomics by revenue in the same principal business activity (Human health activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Utkalgenomics Private Limited
Utkalgenomics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Utkalgenomics Private Limited
Employment history and EPFO contributions of people linked to Utkalgenomics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Utkalgenomics Private Limited
Utkalgenomics Private Limited has 4 board changes on record since 2024: 2 appointments and 2 cessations. The latest: Arijit Jana ceased to be Director on 18 Nov 2024.
Credit Ratings, Litigation & Regulatory Alerts for Utkalgenomics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Utkalgenomics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Utkalgenomics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Utkalgenomics Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Utkalgenomics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Utkalgenomics Private Limited
Utkalgenomics is an active private limited company based in Kolkata, West Bengal, India. The company works in hospitals, within the healthcare industry. It was incorporated on 13 June 2023 (3+ years old) and is registered under CIN U86100WB2023PTC262804.
Utkalgenomics reported revenue of ₹53.26 Lakh for FY 2025.
Utkalgenomics has 2 current directors:
- Priyanka Ray - Director
- Gyana Guru - Director
Utkalgenomics reported a net profit of ₹38,921 (net margin 0.7%) and EBITDA of ₹55,934 (EBITDA margin 1.1%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Utkalgenomics is U86100WB2023PTC262804. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Utkalgenomics was incorporated on 13 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Utkalgenomics by revenue are Drkulkarni Specialty Diagnostic Lab India Private Limited, Sankalp Gynaecare Private Limited, Eye-Care Vinayak Siddhi Hospital Private Limited, NGN Health Care India Private Limited, Humanlife Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (Human health activities).
Arijit Jana ceased to be Director on 18 Nov 2024. Priyanka Ray was appointed as Director on 18 Nov 2024. Gyana Guru was appointed as Director on 16 Sep 2024. Utkalgenomics has 4 board changes on record in total.
The registered office of Utkalgenomics is at Cl – 57 Ground Floor, Sector – 11, Kolkata, West Bengal, India – 700091.
Utkalgenomics has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1.03 Lakh.
Utkalgenomics operates in the healthcare industry, in the hospitals segment.